HR9756Referred to Committee

MAT Act of 2026

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-07-16
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

John J. McGuire III
John J. McGuire III
Republican · VA · Representative
Votes with party: 94.3% (600 recorded votes)

Full profile: /officials/M001239

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on the Judiciary.

2026-07-16

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The federal government would be required to offer medication-assisted treatment for opioid addiction to women in federal prisons, using FDA-approved medications like methadone or buprenorphine to help them manage their addiction. This would affect incarcerated women in the federal prison system who struggle with opioid dependence and would give them access to medical treatment that has been shown to reduce relapse rates and improve outcomes. The Bureau of Prisons would need to implement these treatment programs as part of their healthcare services.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full Bill Text

Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 9756 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 9756 To direct the Director of the Bureau of Prisons to provide medication assisted treatment for opioid addiction to certain women. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES July 16, 2026 Mr. McGuire introduced the following bill; which was referred to the Committee on the Judiciary _______________________________________________________________________ A BILL To direct the Director of the Bureau of Prisons to provide medication assisted treatment for opioid addiction to certain women. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Maternal Access to Treatment Act of 2026'' or the ``MAT Act of 2026''. SEC. 2. MEDICATION ASSISTED TREATMENT. (a) Requirement.--The Director of the Bureau of Prisons shall provide medication assisted treatment (commonly known as ``MAT'') to each pregnant woman in the custody of the Bureau of Prisons addicted to opioids. (b) Exception.--A pregnant woman who is mentally competent may deny the provision of medication assisted treatment under subsection (a). <all>
Open clean-text viewRead on Congress.gov →

Related legislation

Bills by the same sponsor or covering overlapping subjects.